Potentiation of HIV-1 Expression in Microglial Cells by Nicotine: Involvement of Transforming Growth Factor-β1

HIV-1 infection and nicotine addiction are global public health crises. In the central nervous system, HIV-1 causes a devastating neurodegenerative disease. It is well recognized that microglial cells play a pivotal role in the neuropathogenesis of HIV-1 and that drugs of abuse not only contribute t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neuroimmune pharmacology 2008-09, Vol.3 (3), p.143-149
Hauptverfasser: Rock, R. Bryan, Gekker, Genya, Aravalli, Rajagopal N., Hu, Shuxian, Sheng, Wen S., Peterson, Phillip K.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 149
container_issue 3
container_start_page 143
container_title Journal of neuroimmune pharmacology
container_volume 3
creator Rock, R. Bryan
Gekker, Genya
Aravalli, Rajagopal N.
Hu, Shuxian
Sheng, Wen S.
Peterson, Phillip K.
description HIV-1 infection and nicotine addiction are global public health crises. In the central nervous system, HIV-1 causes a devastating neurodegenerative disease. It is well recognized that microglial cells play a pivotal role in the neuropathogenesis of HIV-1 and that drugs of abuse not only contribute to the spread of this agent but may facilitate viral expression in these brain macrophages. Nicotine has been shown to stimulate the production of HIV-1 by in vitro-infected alveolar macrophages, and the HIV-1 protein gp120 binds to nicotinic receptors. In this study, we demonstrated the constitutive expression of nicotinic acetylcholine receptor mRNA in primary human microglial cells and showed that the pretreatment of microglia with nicotine increased HIV-1 expression in a concentration-dependent manner, as measured by p24 antigen levels in culture supernatants. We also found that nicotine robustly altered the gene expression profile of HIV-1-infected microglia and that the transforming growth factor-β1 is involved in the enhanced expression of HIV-1 by nicotine.
doi_str_mv 10.1007/s11481-007-9098-7
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8374949</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1950826640</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3957-df06d6fcd31739f10d59ceccfd5bf3888dd675f9de82ac52a0d619fe150c5a5b3</originalsourceid><addsrcrecordid>eNp1kc1O3DAUhS3UCijtA3RnqevQe5M4sbuoVI34GQnaLmi3lsc_g1HGntqZAV6LB-GZcDQU0UVXPrLv-e6RDyEfEY4RoP-cEVuOVZGVAMGrfo8cImN9hQLaN381F3BA3uV8A9C2LcA-OUAOHTBeH5L4M442jF6NPgYaHT2f_66Qntytk815uvOBXnqd4nLwaqAzOwyZLu7pd6_j6IP9QudhG4etXRXMBLhKKmQX08qHJT1L8Xa8pqdKjzFVjw_4nrx1asj2w_N5RH6dnlzNzquLH2fz2beLSjeihDYOOtM5bRrsG-EQDBPaau0MW7iGc25M1zMnjOW10qxWYDoUziIDzRRbNEfk64673ixW1ugSLqlBrpNfqXQvo_Ly35fgr-UybiVv-la0ogA-PQNS_LOxeZQ3cZNCySxRMOB117VQpnA3VT4o52TdywYEOXUkdx3JSU4dyb546p0nl9mwtOkV-b-mJ0Sjlbc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1950826640</pqid></control><display><type>article</type><title>Potentiation of HIV-1 Expression in Microglial Cells by Nicotine: Involvement of Transforming Growth Factor-β1</title><source>SpringerLink Journals</source><creator>Rock, R. Bryan ; Gekker, Genya ; Aravalli, Rajagopal N. ; Hu, Shuxian ; Sheng, Wen S. ; Peterson, Phillip K.</creator><creatorcontrib>Rock, R. Bryan ; Gekker, Genya ; Aravalli, Rajagopal N. ; Hu, Shuxian ; Sheng, Wen S. ; Peterson, Phillip K.</creatorcontrib><description>HIV-1 infection and nicotine addiction are global public health crises. In the central nervous system, HIV-1 causes a devastating neurodegenerative disease. It is well recognized that microglial cells play a pivotal role in the neuropathogenesis of HIV-1 and that drugs of abuse not only contribute to the spread of this agent but may facilitate viral expression in these brain macrophages. Nicotine has been shown to stimulate the production of HIV-1 by in vitro-infected alveolar macrophages, and the HIV-1 protein gp120 binds to nicotinic receptors. In this study, we demonstrated the constitutive expression of nicotinic acetylcholine receptor mRNA in primary human microglial cells and showed that the pretreatment of microglia with nicotine increased HIV-1 expression in a concentration-dependent manner, as measured by p24 antigen levels in culture supernatants. We also found that nicotine robustly altered the gene expression profile of HIV-1-infected microglia and that the transforming growth factor-β1 is involved in the enhanced expression of HIV-1 by nicotine.</description><identifier>ISSN: 1557-1890</identifier><identifier>EISSN: 1557-1904</identifier><identifier>DOI: 10.1007/s11481-007-9098-7</identifier><identifier>PMID: 18060582</identifier><language>eng</language><publisher>Boston: Springer US</publisher><subject>Biomedical and Life Sciences ; Biomedicine ; Brief Report ; Cell Biology ; Gene expression ; Growth factors ; Immunology ; Neurosciences ; Nicotine ; Pharmacology/Toxicology ; Virology</subject><ispartof>Journal of neuroimmune pharmacology, 2008-09, Vol.3 (3), p.143-149</ispartof><rights>Springer Science+Business Media, LLC 2007</rights><rights>Springer Science+Business Media, LLC 2007.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3957-df06d6fcd31739f10d59ceccfd5bf3888dd675f9de82ac52a0d619fe150c5a5b3</citedby><cites>FETCH-LOGICAL-c3957-df06d6fcd31739f10d59ceccfd5bf3888dd675f9de82ac52a0d619fe150c5a5b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11481-007-9098-7$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11481-007-9098-7$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids></links><search><creatorcontrib>Rock, R. Bryan</creatorcontrib><creatorcontrib>Gekker, Genya</creatorcontrib><creatorcontrib>Aravalli, Rajagopal N.</creatorcontrib><creatorcontrib>Hu, Shuxian</creatorcontrib><creatorcontrib>Sheng, Wen S.</creatorcontrib><creatorcontrib>Peterson, Phillip K.</creatorcontrib><title>Potentiation of HIV-1 Expression in Microglial Cells by Nicotine: Involvement of Transforming Growth Factor-β1</title><title>Journal of neuroimmune pharmacology</title><addtitle>J Neuroimmune Pharmacol</addtitle><description>HIV-1 infection and nicotine addiction are global public health crises. In the central nervous system, HIV-1 causes a devastating neurodegenerative disease. It is well recognized that microglial cells play a pivotal role in the neuropathogenesis of HIV-1 and that drugs of abuse not only contribute to the spread of this agent but may facilitate viral expression in these brain macrophages. Nicotine has been shown to stimulate the production of HIV-1 by in vitro-infected alveolar macrophages, and the HIV-1 protein gp120 binds to nicotinic receptors. In this study, we demonstrated the constitutive expression of nicotinic acetylcholine receptor mRNA in primary human microglial cells and showed that the pretreatment of microglia with nicotine increased HIV-1 expression in a concentration-dependent manner, as measured by p24 antigen levels in culture supernatants. We also found that nicotine robustly altered the gene expression profile of HIV-1-infected microglia and that the transforming growth factor-β1 is involved in the enhanced expression of HIV-1 by nicotine.</description><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Brief Report</subject><subject>Cell Biology</subject><subject>Gene expression</subject><subject>Growth factors</subject><subject>Immunology</subject><subject>Neurosciences</subject><subject>Nicotine</subject><subject>Pharmacology/Toxicology</subject><subject>Virology</subject><issn>1557-1890</issn><issn>1557-1904</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNp1kc1O3DAUhS3UCijtA3RnqevQe5M4sbuoVI34GQnaLmi3lsc_g1HGntqZAV6LB-GZcDQU0UVXPrLv-e6RDyEfEY4RoP-cEVuOVZGVAMGrfo8cImN9hQLaN381F3BA3uV8A9C2LcA-OUAOHTBeH5L4M442jF6NPgYaHT2f_66Qntytk815uvOBXnqd4nLwaqAzOwyZLu7pd6_j6IP9QudhG4etXRXMBLhKKmQX08qHJT1L8Xa8pqdKjzFVjw_4nrx1asj2w_N5RH6dnlzNzquLH2fz2beLSjeihDYOOtM5bRrsG-EQDBPaau0MW7iGc25M1zMnjOW10qxWYDoUziIDzRRbNEfk64673ixW1ugSLqlBrpNfqXQvo_Ly35fgr-UybiVv-la0ogA-PQNS_LOxeZQ3cZNCySxRMOB117VQpnA3VT4o52TdywYEOXUkdx3JSU4dyb546p0nl9mwtOkV-b-mJ0Sjlbc</recordid><startdate>200809</startdate><enddate>200809</enddate><creator>Rock, R. Bryan</creator><creator>Gekker, Genya</creator><creator>Aravalli, Rajagopal N.</creator><creator>Hu, Shuxian</creator><creator>Sheng, Wen S.</creator><creator>Peterson, Phillip K.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>200809</creationdate><title>Potentiation of HIV-1 Expression in Microglial Cells by Nicotine: Involvement of Transforming Growth Factor-β1</title><author>Rock, R. Bryan ; Gekker, Genya ; Aravalli, Rajagopal N. ; Hu, Shuxian ; Sheng, Wen S. ; Peterson, Phillip K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3957-df06d6fcd31739f10d59ceccfd5bf3888dd675f9de82ac52a0d619fe150c5a5b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Brief Report</topic><topic>Cell Biology</topic><topic>Gene expression</topic><topic>Growth factors</topic><topic>Immunology</topic><topic>Neurosciences</topic><topic>Nicotine</topic><topic>Pharmacology/Toxicology</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rock, R. Bryan</creatorcontrib><creatorcontrib>Gekker, Genya</creatorcontrib><creatorcontrib>Aravalli, Rajagopal N.</creatorcontrib><creatorcontrib>Hu, Shuxian</creatorcontrib><creatorcontrib>Sheng, Wen S.</creatorcontrib><creatorcontrib>Peterson, Phillip K.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of neuroimmune pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rock, R. Bryan</au><au>Gekker, Genya</au><au>Aravalli, Rajagopal N.</au><au>Hu, Shuxian</au><au>Sheng, Wen S.</au><au>Peterson, Phillip K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Potentiation of HIV-1 Expression in Microglial Cells by Nicotine: Involvement of Transforming Growth Factor-β1</atitle><jtitle>Journal of neuroimmune pharmacology</jtitle><stitle>J Neuroimmune Pharmacol</stitle><date>2008-09</date><risdate>2008</risdate><volume>3</volume><issue>3</issue><spage>143</spage><epage>149</epage><pages>143-149</pages><issn>1557-1890</issn><eissn>1557-1904</eissn><abstract>HIV-1 infection and nicotine addiction are global public health crises. In the central nervous system, HIV-1 causes a devastating neurodegenerative disease. It is well recognized that microglial cells play a pivotal role in the neuropathogenesis of HIV-1 and that drugs of abuse not only contribute to the spread of this agent but may facilitate viral expression in these brain macrophages. Nicotine has been shown to stimulate the production of HIV-1 by in vitro-infected alveolar macrophages, and the HIV-1 protein gp120 binds to nicotinic receptors. In this study, we demonstrated the constitutive expression of nicotinic acetylcholine receptor mRNA in primary human microglial cells and showed that the pretreatment of microglia with nicotine increased HIV-1 expression in a concentration-dependent manner, as measured by p24 antigen levels in culture supernatants. We also found that nicotine robustly altered the gene expression profile of HIV-1-infected microglia and that the transforming growth factor-β1 is involved in the enhanced expression of HIV-1 by nicotine.</abstract><cop>Boston</cop><pub>Springer US</pub><pmid>18060582</pmid><doi>10.1007/s11481-007-9098-7</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1557-1890
ispartof Journal of neuroimmune pharmacology, 2008-09, Vol.3 (3), p.143-149
issn 1557-1890
1557-1904
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8374949
source SpringerLink Journals
subjects Biomedical and Life Sciences
Biomedicine
Brief Report
Cell Biology
Gene expression
Growth factors
Immunology
Neurosciences
Nicotine
Pharmacology/Toxicology
Virology
title Potentiation of HIV-1 Expression in Microglial Cells by Nicotine: Involvement of Transforming Growth Factor-β1
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T08%3A47%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Potentiation%20of%20HIV-1%20Expression%20in%20Microglial%20Cells%20by%20Nicotine:%20Involvement%20of%20Transforming%20Growth%20Factor-%CE%B21&rft.jtitle=Journal%20of%20neuroimmune%20pharmacology&rft.au=Rock,%20R.%20Bryan&rft.date=2008-09&rft.volume=3&rft.issue=3&rft.spage=143&rft.epage=149&rft.pages=143-149&rft.issn=1557-1890&rft.eissn=1557-1904&rft_id=info:doi/10.1007/s11481-007-9098-7&rft_dat=%3Cproquest_pubme%3E1950826640%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1950826640&rft_id=info:pmid/18060582&rfr_iscdi=true